Angiotensin receptor
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| angiotensin II receptor, type 1
| |
| Identifiers | |
| Symbol | AGTR1 |
| Alt. Symbols | AGTR1B |
| Entrez | 185 |
| HUGO | 336 |
| OMIM | 106165 |
| RefSeq | NM_000685 |
| UniProt | P30556 |
| Other data | |
| Locus | Chr. 3 q21-q25 |
| angiotensin II receptor, type 2
| |
| Identifiers | |
| Symbol | AGTR2 |
| Entrez | 186 |
| HUGO | 338 |
| OMIM | 300034 |
| RefSeq | NM_000686 |
| UniProt | P50052 |
| Other data | |
| Locus | Chr. X q22-q23 |
The angiotensin receptors are a class of G protein-coupled receptors with angiotensins as ligands.[1] They are important in the renin-angiotensin system: they are responsible for the signal transduction of the main effector hormone.[2]
Contents |
Structure
The AT1 and AT2 receptors share a sequence identity of ~30%, but have a similar affinity for angiotensin II, which is their main ligand.
Members
Overview table
| Receptor | Mechanism [3] |
|---|---|
| AT1 | |
| AT2 | |
| AT3 | |
| AT4 |
AT1
The AT1 receptor is the best elucidated angiotensin receptor. It is coupled to phospholipase C and angiotensin II increases the cytosolic Ca2+ level. It also inhibits adenylate cyclase and activate various tyrosine kinases.[2] Effects mediated by the AT1 receptor include vasoconstriction, aldosterone synthesis and secretion, increased vasopressin secretion, cardiac hypertrophy, augmentation of peripheral noradrenergic activity, vascular smooth muscle cells proliferation, decreased renal blood flow, renal renin inhibition, renal tubular sodium reuptake, modulation of central sympathetic nervous system activity, cardiac contractility, central osmocontrol and extracellular matrix formation.[4] It is encoded by the gene AGTR1.
AT2
AT2 receptors are more plentiful in the fetus and neonate. Effects mediated by the AT2 receptor include inhibition of cell growth, fetal tissue development, modulation of extracellular matrix, neuronal regeneration, apoptosis, cellular differentiation and maybe vasodilation.
AT3 and AT4
Other poorly characterized subtypes include the AT3 and AT4 receptors. The AT4 receptor is activated by the angiotensin II metabolite angiotensin IV, and may play a role in regulation of the CNS extracellular matrix.
See also
References
- ↑ de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T (2000). "International union of pharmacology. XXIII. The angiotensin II receptors". Pharmacol. Rev. 52 (3): 415–72. PMID 10977869.
- ↑ 2.0 2.1 Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S (2007). "Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology". Clin. Sci. 112 (8): 417–28. doi:10.1042/CS20060342. PMID 17346243.
- ↑ Unless else specified in box, then ref is: Senselab
- ↑ Catt KJ, Mendelsohn FA, Millan MA, Aguilera G (1984). "The role of angiotensin II receptors in vascular regulation". J. Cardiovasc. Pharmacol. 6 Suppl 4: S575–86. PMID 6083400.
External links
Neuropeptide receptors | |
|---|---|
| Hypothalamic hormone receptors | CRH - FSH - LHRH - TRH - Somatostatin |
| Pituitary hormone receptors | Vasopressin (1A, 1B, 2) - Oxytocin - LHCG - Type I cytokine receptor (GH, Prolactin) - TSH |
| Other hormone receptors | Atrial natriuretic factor - Calcitonin - Cholecystokinin (A, B) - VIP |
| Opioid receptors | Delta - Kappa - Mu - Sigma (1, 2) - Nociceptin |
| Other neuropeptide receptors | Angiotensin - Bradykinin (B1, B2) / Tachykinin (TACR1) - Calcitonin gene-related peptide - Galanin - GPCR neuropeptide (B/W, FF, S, Y) - Neurotensin |
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

